Management of Severe Ileocolitis with Methylprednisolone

Initial Treatment and Assessment

For severe ileocolitis requiring intravenous methylprednisolone 60mg daily, treatment should be continued for 3-5 days with assessment of response, and should not extend beyond 7 days if the patient is not responding 1, 2
Assess clinical and biochemical response after 3 days of intravenous methylprednisolone 60mg daily to determine whether the patient is responding or requires escalation to salvage therapy 2
The typical assessment window is 3-5 days, during which you should monitor stool frequency, presence of blood, fever, heart rate, and inflammatory markers (CRP, albumin) 1, 2
Do not continue intravenous steroids beyond 7-10 days in non-responding patients, as extending therapy beyond this point carries no additional benefit and only increases toxicity 2

Once the patient demonstrates clinical response (typically within 3-5 days), transition to oral prednisolone 40mg daily 1, 3, 4
Taper prednisolone gradually over 8 weeks according to severity and patient response—more rapid reduction is associated with early relapse 1, 3, 4

Concomitant intravenous metronidazole is often advisable during the initial 3-5 day period, as it may be difficult to distinguish between active inflammatory disease and septic complications in severe ileocolitis 1, 3, 4
If the patient fails to respond adequately after 3-5 days of intravenous steroids, initiate salvage therapy with infliximab or consider surgical consultation rather than prolonging steroid exposure 2, 7
Total steroid exposure matters for outcomes—the goal is to achieve remission and transition to steroid-sparing maintenance therapy (azathioprine 1.5-2.5 mg/kg/day or mercaptopurine 0.75-1.5 mg/kg/day) rather than prolonged corticosteroid use 1, 3, 4

There is no benefit to using methylprednisolone doses higher than 60mg daily—meta-regression analysis controlling for baseline disease severity showed no correlation between doses above 60mg and colectomy risk 7
The 60mg daily dose of methylprednisolone is equivalent to approximately 400mg hydrocortisone daily, and methylprednisolone has less mineralocorticoid effect, causing significantly less hypokalemia 2